Discover how Regulation N enforces the CARD Act and Dodd-Frank Act, preventing misleading mortgage ads and ensuring transparent credit product promotions.

The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. President Trump and HHS Secretary Kennedy emphasize transparency and ...

Marketers must make sure they’re clued up about what they can and can’t say when promoting their brand. Ellen Forrest-Charde, partner at Squire, Sanders & Dempsey LLP, examines the common pitfalls ...

The US Food and Drug Administration on Tuesday released approximately 100 warning letters it had sent to drug companies on September 9, alleging that the companies made false or misleading claims on ...

The American Society of Bariatric Physicians supports the FDA’s decision to issue warnings to surgery centers and 1-800-GET-THIN for misleading advertisements, according to a news release. Last week, ...

NEW DELHI: Five years ago, the Union Health Ministry proposed significant changes to amend the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, which aimed to take stringent action ...

New Delhi: The Central Consumer Protection Authority (CCPA) has ordered Rapido (Roppen Transportation Services Pvt. Ltd.) to pay penalty of Rs 10 lakh for publishing misleading advertisement and ...